The Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial is a multicenter, randomized,
controlled clinical trial of 1400 patients that will include approximately 60 enrolling
sites. The study hypotheses are that treatment of hyperglycemic acute ischemic stroke
patients with targeted glucose concentration (80mg/dL - 130 mg/dL) will be safe and result in
improved 3 month outcome after stroke.
Phase:
Phase 3
Details
Lead Sponsor:
University of Virginia
Collaborators:
Medical University of South Carolina National Institute of Neurological Disorders and Stroke (NINDS) Neurological Emergencies Treatment Trials Network (NETT)